Implantable oxygen-eating batteries help kill cancer
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Despite decades of research and tens of billions of dollars for research and treatments worldwide, the battle against cancer continues.
Each year, 700,000 people die due to antibiotic resistance. A growing global population unfortunately generates a growing resistance to established antibiotic treatments—a threat that has been met with insufficient funding ...
Oct 13, 2022
0
177
Implantable devices that release insulin into the body hold promise as an alternative way to treat diabetes without insulin injections or cannula insertions. However, one obstacle that has prevented their use so far is that ...
Aug 5, 2022
0
99
A nanofiber-based biodegradable millirobot called Fibot was successfully developed in research led by a scholar from City University of Hong Kong (CityU). Fibot can move in the intestines and degrade in response to the pH ...
Apr 29, 2022
0
32
Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While the drugs are effective for a time, most patients eventually develop resistance to these therapies.
Nov 5, 2021
0
18
In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples.
May 26, 2021
0
326
Despite the limited supply of organs available for patients on waitlists for transplantation, organs from older, deceased donors are frequently discarded or not utilized. Available older organs have the potential to close ...
Aug 27, 2020
0
317
Something like a quarter of the world's population suffers from chronic pain at some point in their lives. As opposed to acute pain—for example, the feeling after hitting your finger with a hammer—chronic pain may not ...
Aug 19, 2020
0
279
A team of scientists from Immanuel Kant Baltic Federal University together with their colleagues from NUST MISiS and RWTH Aachen University (Germany) compared different treatments against liver fibrosis and published the ...
Jan 21, 2020
0
3
A newly engineered peptide called IBP-CP24 has the potential to be further developed as a long-acting anti-HIV drug that can be used alone or in combination with a broad neutralizing antibody for the treatment and prevention ...
Dec 5, 2019
0
4